Rigel Pharmaceuticals (RIGL) Restructuring Costs (2013 - 2016)
Rigel Pharmaceuticals (RIGL) posted quarterly Restructuring Costs of $5.8 million for Q3 2016, up 239.41% quarter-over-quarter from $1.7 million in Q3 2013.
Rigel Pharmaceuticals (RIGL) Restructuring Costs (2013 - 2016) Analysis & Trends
Rigel Pharmaceuticals' Restructuring Costs history runs 2 years deep, the most recent figure standing at $5.8 million for Q3 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Rigel Pharmaceuticals | 795.39 Mn | 700.06 Mn | 70.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | 5.77 Mn |
| Sep 30, 2013 | 1.70 Mn |